When the COVID-19 pandemic is slowing, low-cost, recurring screening of asymptomatic people could decrease infections and deaths and be cost-effective.
When the COVID-19 pandemic is slowing, low-cost, recurring screening of asymptomatic people could decrease infections and deaths and be cost-effective.